Essential Feasibility Metrics for Selecting the Right Clinical Trial Sites

Choosing the right investigational sites is one of the most critical factors influencing the success of a clinical trial. Site feasibility assessments go beyond basic questionnaires—they require evaluating robust metrics that predict a site’s ability to deliver high-quality data, recruit effectively, and meet regulatory standards. This guide explores key feasibility metrics sponsors and CROs should use to select optimal clinical trial sites.

Why Metrics Matter in Site Feasibility

Traditional site selection methods often rely on subjective impressions or past relationships. However, with rising regulatory expectations and protocol complexity, data-driven site selection is now essential. Metrics offer:

• Quantifiable insight into site capabilities
• Better forecasting for patient enrollment
• Improved operational planning
• Reduced risk of non-compliance or delays

Resources such as StabilityStudies.in offer best practices for site documentation and trial integrity.

Top Feasibility Metrics to Evaluate Trial Sites

1. Historical Patient Recruitment Performance

• Number of patients enrolled in previous trials in the same indication
• Speed of enrollment compared to target timelines
• Drop-out and screen failure rates

2. Study Start-Up Timelines

• Average time for Ethics Committee (EC) approval
• Contract finalization time with the sponsor/CRO
• Site initiation visit (SIV) readiness time

3. Regulatory and Audit History

• Number of audits in the last 5 years
• Findings and CAPA responses, if applicable
• Compliance with GMP audit checklist and ICH-GCP standards

4. Therapeutic Area Experience

• Number of trials conducted in the relevant indication
• Specific expertise of principal investigator (PI)
• Availability of trained sub-investigators and coordinators

5. Site Infrastructure Readiness

• Availability of diagnostic tools, labs, and investigational pharmacies
• Functionality of EDC systems and internet bandwidth
• Facilities for IP storage, sample shipment, and patient comfort

Scoring and Ranking Feasibility Metrics

To effectively use metrics, develop a scoring matrix that assigns weights to each criterion based on study priorities. For example:

• Patient Recruitment History: 35%
• Startup Timelines: 25%
• PI and Staff Experience: 15%
• Infrastructure Readiness: 15%
• Audit/Compliance History: 10%

Sites are scored and ranked. Sites below a threshold may be excluded or flagged for risk mitigation.

Digital Tools to Track and Analyze Metrics

• Clinical Trial Management Systems (CTMS)
• Feasibility dashboards within eTMF platforms
• Excel feasibility scoring templates
• CRA report-based feasibility validations

These tools help gather and compare site data across global networks efficiently.

Integrating KPIs into Site Selection SOPs

Use internal Pharma SOP guidelines to standardize feasibility evaluations across studies. SOPs should define:

• What data should be requested
• How metrics are scored and interpreted
• Who is responsible for final site approval

Having consistent feasibility practices improves quality and regulatory inspection readiness.

Regulatory Expectations and Documentation

According to USFDA and EMA, site selection must be justified with documented feasibility assessments. Sponsors must ensure that the process is auditable and that decisions are supported by objective data.

Challenges and Mitigation Strategies

• Incomplete Data from Sites: Encourage sites to provide performance metrics in feasibility questionnaires.
• Overestimated Recruitment: Cross-check against therapeutic benchmarks or past enrollment logs.
• Resource Constraints: Consider central site services or additional monitoring resources.

Conclusion

Feasibility metrics offer a strategic advantage in selecting high-performing clinical trial sites. By using a structured, metrics-driven approach to feasibility, sponsors can reduce risk, optimize enrollment, and ensure quality and compliance throughout the study lifecycle. Effective site selection starts with objective data, not guesswork.